Blood pressure level and kidney disease progression: Do we really need to go to 130/80 mm Hg?

被引：1
作者：
Abu Jawdeh, Bassam G. [1 ]
Rahman, Mahboob [1 ]
机构：
[1] Univ Hosp Case Med Ctr, Div Nephrol & Hypertens, Cleveland, OH 44106 USA
来源：
CURRENT HYPERTENSION REPORTS | 2009年 / 11卷 / 05期
关键词：
ANGIOTENSIN-CONVERTING-ENZYME; STAGE RENAL-DISEASE; DEPENDENT DIABETES-MELLITUS; 9 GENE MYH9; CARDIOVASCULAR OUTCOMES; HYPERTENSIVE PATIENTS; CLINICAL PROTEINURIA; RISK-FACTOR; FOLLOW-UP; INHIBITION;
D O I：
10.1007/s11906-009-0060-3
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Current guidelines recommend a blood pressure goal of less than 130/80 mm Hg in patients with chronic kidney disease. Considerable epidemiologic observational data, post hoc analyses of clinical trials, and meta-analyses support this goal, particularly in patients with proteinuria. Although prospective clinical trials have not shown a clear benefit, recent data indicate that a longer duration of follow-up may be needed to assess the effects of different blood pressure goals. While we await the results of several ongoing and planned studies in this area, the current recommendations of a blood pressure goal less than 130/80 mm Hg appear reasonable.
引用
收藏
页码：363 / 367
页数：5
相关论文
共 73 条
  • [11] IMPROVED KIDNEY-FUNCTION WITH CILAZAPRIL IN HYPERTENSIVE TYPE-II DIABETICS WITH CHRONIC-RENAL-FAILURE
    BURSZTYN, M
    KOBRIN, I
    FIDEL, J
    BENISHAY, D
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 (03) : 337 - 341
  • [12] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [13] Prevalence of chronic kidney disease in the United States
    Coresh, Josef
    Selvin, Elizabeth
    Stevens, Lesley A.
    Manzi, Jane
    Kusek, John W.
    Eggers, Paul
    Van Lente, Frederick
    Levey, Andrew S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17): : 2038 - 2047
  • [14] Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
    de Galan, Bastiaan E.
    Perkovic, Vlado
    Ninomiya, Toshiharu
    Pillai, Avinesh
    Patel, Anushka
    Cass, Alan
    Neal, Bruce
    Poulter, Neil
    Harrap, Stephen
    Mogensen, Carl-Erik
    Cooper, Mark
    Marre, Michel
    Williams, Bryan
    Hamet, Pavel
    Mancia, Giuseppe
    Woodward, Mark
    Glasziou, Paul
    Grobbee, Diederick E.
    MacMahon, Stephen
    Chalmers, John
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (04): : 883 - 892
  • [15] Clinical epidemiology of cardiovascular disease in chronic renal disease
    Foley, RN
    Parfrey, PS
    Sarnak, MJ
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) : S112 - S119
  • [16] Hypertension-Associated Kidney Disease: Perhaps no More
    Freedman, Barry I.
    Sedor, John R.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (11): : 2047 - 2051
  • [17] Polymorphisms in the Nonmuscle Myosin Heavy Chain 9 Gene (MYH9) Are Associated with Albuminuria in Hypertensive African Americans: The HyperGEN Study
    Freedman, Barry I.
    Kopp, Jeffrey B.
    Winkler, Cheryl A.
    Nelson, George W.
    Rao, D. C.
    Eckfeldt, John H.
    Leppert, Mark F.
    Hicks, Pamela J.
    Divers, Jasmin
    Langefeld, Carl D.
    Hunt, Steven C.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (06) : 626 - 632
  • [18] Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans
    Freedman, Barry I.
    Hicks, Pamela J.
    Bostrom, Meredith A.
    Cunningham, Mary E.
    Liu, Yongmei
    Divers, Jasmin
    Kopp, Jeffrey B.
    Winkler, Cheryl A.
    Nelson, George W.
    Langefeld, Carl D.
    Bowden, Donald W.
    [J]. KIDNEY INTERNATIONAL, 2009, 75 (07) : 736 - 745
  • [19] Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
    Gerstein, HC
    Mann, JFE
    Yi, QL
    Zinman, B
    Dinneen, SF
    Hoogwerf, B
    Hallé, JP
    Young, J
    Rashkow, A
    Joyce, C
    Nawaz, S
    Yusuf, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (04): : 421 - 426
  • [20] Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    Go, AS
    Chertow, GM
    Fan, DJ
    McCulloch, CE
    Hsu, CY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) : 1296 - 1305
12345678